Table I.
Diagnosis (Total Cases) | Average age (years) | Sex (M:F) | HIV status (% positive) | Morphology | Lesion Distribution |
---|---|---|---|---|---|
MF (22) | 52.5 | 13:9 | 4/22 (18.2%) | -Macules/patches only (6) -Plaques only (3) -Patches, plaques, tumors (3) -Erythroderma (8) -Erythroderma, plaques (1) -Erythroderma, tumors (1) |
-Gen (10) -T predominant (3) -T, E (8) -E predominant (1) |
PTCL NOS* (1) | 32 | 1:0 | 1/1 (100%) | -Nodules and tumors | -Arm, T, H/N in a sporotrichoid-like pattern |
Plasmablastic lymphoma (2) | 37 | 2:0 | 2/2 (100%) | -Nodules and tumors | -Genitals (1) -T, LE (1) |
EBV(+) CTCL (1) | 32 | 1:0 | 1/1 (100%) | -Necrotic plaque with perforation | -H/N, hard palate |
SPTCL (1) | 39 | 0:1 | 1/1 (100%) | -Subcutaneous nodules | -T, UE |
ALI (8) | 49 | 3:1 | 2/8 (25%) | -Plaques (5) -Erythroderma (3) |
-Gen (4) -T, E (4) |
Reactive processes (3) | 56 | 3:0 | 1/3 (33%) | -Erythroderma (2) -Atrophic plaques (1) |
-Gen (2) -T, LE (1) |
ALI, atypical lymphocytic infiltrate; EBV, Epstein–Barr virus; MF, mycosis fungoides; PTCL NOS, peripheral T-cell lymphoma not otherwise specified; SPTCL, subcutaneous panniculitis-like T-cell lymphoma; Gen, generalized; T, trunk; LE, lower extremities; E, extremities; H/N, head and neck; UE, upper extremities